Biocodex

Biocedex

Université De Poitiers

Marie-Emmanuelle Le Guern

Bernard M Hublot

Philippe Girard

Marc Verleye

Jean-Marie Gillardin

Laurence Berthon-Cedille

Rene Levy

Gilles Renaud

Paul Bernasconi

Amandine Everard

Emmanuelle Simon O'Brien

Herve Groux

Patrice D Cani

Jean-Marie Lefevre

Myriam Tirault

Bertrand Debaene

René Levy

Lucie Geurts

Véronique Riban

Emilie Fargier

Bernard Hublot

Anne Benoist

Xavier Zeisser

Patrice Tewa

Veronique Riban

The present invention relates toyeast cells, for use in the prevention or treatment of mood disorders, in a person.

for the treatment of mood disorders

The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof,for use in the prevention or treatment of obsessions and/or compulsions in an individual.

Pharmacological treatment of obsessive-compulsive disorder

The present invention relates to a compound of the following formula (I): 

Compounds and methods for treating autism spectrum disorders

The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylizedas an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilizedpowder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension ofto be administered to an individual upon opening of the vial.

Compositions and methods for preventing infections

The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.

Treatment of degenerations and light-induced damage to the retina

The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.

Medicinal product for treating gastrointestinal ulcers

Compound for use in the treatment of peripheral neuropathies

The present invention relates to a pharmaceutical composition comprising as active substances: and

Synergistic combination of analgesic compounds

The present invention relates to a pharmaceutical composition comprising as active substances: and especially for its use in the prevention or treatment of pain.

The present invention relates to the use of at least one compound of formula (I) below: or at least one of the pharmaceutically acceptable salts thereof, for the preparation of a medicament intended for the prevention or for the treatment of cerebral edemas.

Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas

This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.

Neuroprotective compounds and pharmaceutical compositions comprising them

The present invention relates to a method of treating or preventing weight loss of patients with inflammatory bowel diseases comprising administering to said patients an effective amount of

Method for treating weight loss in patients suffering from inflammatory bowel diseases

The present invention relates to the use of at least one compound of formula (I) below: or of its pharmaceutically acceptable salts, in the preparation of a medicament for the prevention or treatment of cerebral oedemas.

Growing community of inventors

Compiegne, France

Marie-Emmanuelle Le Guern